Alexza Pharmaceuticals Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements
Alexza Pharmaceuticals Inc. reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements of $0 for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-13.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements · last filed 2016-05-13
- Alexza Pharmaceuticals Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2016-03-31 was $0.00, a 100.00% decline year-over-year.
- Alexza Pharmaceuticals Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2015-12-31 was $0.00.
- Alexza Pharmaceuticals Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2015-09-30 was $0.00.
- Alexza Pharmaceuticals Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2015-06-30 was $1.00K, a 0.00% change year-over-year.
- Alexza Pharmaceuticals Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2015 was $868.00K, a 245.82% increase from fiscal 2014.
- Alexza Pharmaceuticals Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2014 was $251.00K, a 97.57% decline from fiscal 2013.
- Alexza Pharmaceuticals Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2013 was $10.31M, a 106.26% increase from fiscal 2012.
- Alexza Pharmaceuticals Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2012 was $5.00M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 3 month as first filed | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 6 month as first filed | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 12 month |
|---|---|---|---|---|---|---|
| 2016-03-31 | $0.00 10-Q · filed 2016-05-13 | $0.00 derived: sum of 2 quarters · filed 2016-05-13 | $0.00 derived: sum of 3 quarters · filed 2016-05-13 | $1.00K derived: sum of 4 quarters · filed 2016-05-13 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | $0.00 derived: sum of 2 quarters · filed 2016-03-28 | $1.00K derived: sum of 3 quarters · filed 2016-03-28 | $868.00K 10-K · filed 2016-03-28 | ||
| 2015-09-30 | $0.00 10-Q · filed 2015-11-05 | $1.00K derived: sum of 2 quarters · filed 2015-11-05 | $868.00K 10-Q · filed 2015-11-05 | $868.00K derived: sum of 4 quarters · filed 2016-05-13 | ||
| 2015-06-30 | $1.00K 10-Q · filed 2015-08-06 | $868.00K 10-Q · filed 2015-08-06 | $868.00K derived: sum of 3 quarters · filed 2016-05-13 | $868.00K derived: sum of 4 quarters · filed 2016-05-13 | ||
| 2015-03-31 | $867.00K 10-Q · filed 2016-05-13 | $867.00K derived: sum of 2 quarters · filed 2016-05-13 | $867.00K derived: sum of 3 quarters · filed 2016-05-13 | $868.00K derived: sum of 4 quarters · filed 2016-05-13 | ||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | $0.00 derived: sum of 2 quarters · filed 2016-03-28 | $1.00K derived: sum of 3 quarters · filed 2016-03-28 | $251.00K 10-K · filed 2016-03-28 | ||
| 2014-09-30 | $0.00 10-Q · filed 2015-11-05 | $1.00K derived: sum of 2 quarters · filed 2015-11-05 | $251.00K 10-Q · filed 2015-11-05 | $251.00K derived: sum of 4 quarters · filed 2015-11-05 | ||
| 2014-06-30 | $1.00K 10-Q · filed 2015-08-06 | $251.00K 10-Q · filed 2015-08-06 | $251.00K derived: sum of 3 quarters · filed 2015-08-06 | $564.00K derived: sum of 4 quarters · filed 2015-08-06 | ||
| 2014-03-31 | $250.00K 10-Q · filed 2015-05-11 | $250.00K derived: sum of 2 quarters · filed 2015-05-11 | $563.00K derived: sum of 3 quarters · filed 2015-05-11 | $563.00K derived: sum of 4 quarters · filed 2015-05-11 | ||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $313.00K derived: sum of 2 quarters · filed 2015-03-13 | $313.00K derived: sum of 3 quarters · filed 2015-03-13 | $10.31M 10-K · filed 2015-03-13 | ||
| 2013-09-30 | $313.00K 10-Q · filed 2014-11-05 | $313.00K derived: sum of 2 quarters · filed 2014-11-05 | $10.31M 10-Q · filed 2014-11-05 | |||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-07 | $10.00M 10-Q · filed 2013-08-14 | $0.00 10-Q · filed 2014-08-07 | $10.00M 10-Q · filed 2013-08-14 | ||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-25 | $0.00 derived: sum of 2 quarters · filed 2014-03-25 | $0.00 derived: sum of 3 quarters · filed 2014-03-25 | $5.00M 10-K · filed 2014-03-25 | ||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $0.00 derived: sum of 2 quarters · filed 2013-11-06 | $5.00M 10-Q · filed 2013-11-06 | |||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $5.00M 10-Q · filed 2013-08-14 | ||||
| 2012-03-31 | $5.00M 10-Q · filed 2013-05-14 |